Christopher R. Stone

Array ( [id] => 5398408 [patent_doc_number] => 20090318471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'New Salts and Crystalline Salt Forms of an Indolinone Derivative' [patent_app_type] => utility [patent_app_number] => 12/303278 [patent_app_country] => US [patent_app_date] => 2007-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 57 [patent_no_of_words] => 27719 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318471.pdf [firstpage_image] =>[orig_patent_app_number] => 12303278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4772749 [patent_doc_number] => 20080058408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Low-dose doxepin for treatment of sleep disorders in elderly patients' [patent_app_type] => utility [patent_app_number] => 11/804722 [patent_app_country] => US [patent_app_date] => 2007-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12827 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058408.pdf [firstpage_image] =>[orig_patent_app_number] => 11804722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939453 [patent_doc_number] => 20080076772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Anti-Inflammatory Agents' [patent_app_type] => utility [patent_app_number] => 11/576115 [patent_app_country] => US [patent_app_date] => 2005-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5769 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076772.pdf [firstpage_image] =>[orig_patent_app_number] => 11576115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6424781 [patent_doc_number] => 20100168093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'SUBSTITUTED 3-AMINO-4 -HYDROXY PYRROLIDINES COMPOUNDS, THEIR PREPARATION AND USE AS MEDICAMENTS' [patent_app_type] => utility [patent_app_number] => 12/226560 [patent_app_country] => US [patent_app_date] => 2007-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78784 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168093.pdf [firstpage_image] =>[orig_patent_app_number] => 12226560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6546131 [patent_doc_number] => 20100016340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'PHARMACEUTICAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/298338 [patent_app_country] => US [patent_app_date] => 2007-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36866 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016340.pdf [firstpage_image] =>[orig_patent_app_number] => 12298338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887587 [patent_doc_number] => 20080261919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Camptothecin-analog with a novel, \"flipped\" lactone-stable, E-ring and methods for making and using same' [patent_app_type] => utility [patent_app_number] => 11/788223 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29671 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261919.pdf [firstpage_image] =>[orig_patent_app_number] => 11788223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5316583 [patent_doc_number] => 20090281181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Pharmaceutical Composition for Treating or Preventing Degenerative and Inflammatory Diseases' [patent_app_type] => utility [patent_app_number] => 12/296747 [patent_app_country] => US [patent_app_date] => 2007-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11375 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281181.pdf [firstpage_image] =>[orig_patent_app_number] => 12296747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7568017 [patent_doc_number] => 20110288080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'Nitrofuran Compounds for the Treatment of Cancer and Angiogenesis' [patent_app_type] => utility [patent_app_number] => 12/225202 [patent_app_country] => US [patent_app_date] => 2007-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20617 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288080.pdf [firstpage_image] =>[orig_patent_app_number] => 12225202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220095 [patent_doc_number] => 20100055190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Sterol-Containing Compositions' [patent_app_type] => utility [patent_app_number] => 12/282171 [patent_app_country] => US [patent_app_date] => 2007-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3101 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055190.pdf [firstpage_image] =>[orig_patent_app_number] => 12282171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374847 [patent_doc_number] => 20090312408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'ISOFLAVAN AND ISOFLAVENE COMPOUNDS AND THEIR USE AS ANGIOGENESIS INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/280345 [patent_app_country] => US [patent_app_date] => 2007-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4903 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312408.pdf [firstpage_image] =>[orig_patent_app_number] => 12280345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085909 [patent_doc_number] => 20070275960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Phenyl and pyridyl compounds for inflammation and immune-related uses' [patent_app_type] => utility [patent_app_number] => 11/698982 [patent_app_country] => US [patent_app_date] => 2007-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34140 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 44 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275960.pdf [firstpage_image] =>[orig_patent_app_number] => 11698982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558930 [patent_doc_number] => 20090270507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'Concentrated Liquid Thyroid Hormone Composition' [patent_app_type] => utility [patent_app_number] => 12/160292 [patent_app_country] => US [patent_app_date] => 2007-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7008 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270507.pdf [firstpage_image] =>[orig_patent_app_number] => 12160292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5063628 [patent_doc_number] => 20070225268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'METHOD TO TREAT NEOPLASMS VIA GADOLINIUM STEREOTACTIC SYNCHROTRON RADIATION' [patent_app_type] => utility [patent_app_number] => 11/618421 [patent_app_country] => US [patent_app_date] => 2006-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8125 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225268.pdf [firstpage_image] =>[orig_patent_app_number] => 11618421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8713302 [patent_doc_number] => 08399442 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Pharmaceutical compounds' [patent_app_type] => utility [patent_app_number] => 12/159054 [patent_app_country] => US [patent_app_date] => 2006-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 95600 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12159054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5113691 [patent_doc_number] => 20070197607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Continuous Dosing Regimen' [patent_app_type] => utility [patent_app_number] => 11/615328 [patent_app_country] => US [patent_app_date] => 2006-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11274 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20070197607.pdf [firstpage_image] =>[orig_patent_app_number] => 11615328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070335 [patent_doc_number] => 20070191437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Continuous Dosing Regimen' [patent_app_type] => utility [patent_app_number] => 11/615322 [patent_app_country] => US [patent_app_date] => 2006-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11294 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191437.pdf [firstpage_image] =>[orig_patent_app_number] => 11615322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368539 [patent_doc_number] => 20090306098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'COMBINATION OF ROSCOVITINE AND A HDCA INHIBITOR TO TREAT PROLIFERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/093418 [patent_app_country] => US [patent_app_date] => 2006-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9467 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306098.pdf [firstpage_image] =>[orig_patent_app_number] => 12093418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5095148 [patent_doc_number] => 20070116757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Methylene Blue Derivatives' [patent_app_type] => utility [patent_app_number] => 11/557889 [patent_app_country] => US [patent_app_date] => 2006-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6695 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20070116757.pdf [firstpage_image] =>[orig_patent_app_number] => 11557889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4971976 [patent_doc_number] => 20070111979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Methods of treating cell proliferative disorders using a compressed temozolomide dosing schedule' [patent_app_type] => utility [patent_app_number] => 11/593839 [patent_app_country] => US [patent_app_date] => 2006-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8221 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111979.pdf [firstpage_image] =>[orig_patent_app_number] => 11593839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9875556 [patent_doc_number] => 08962825 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-24 [patent_title] => 'Hydroxamates as inhibitors of histone deacetylase' [patent_app_type] => utility [patent_app_number] => 12/446267 [patent_app_country] => US [patent_app_date] => 2006-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22635 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12446267 [rel_patent_id] =>[rel_patent_doc_number] =>)